Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
Akoya Biosciences(AKYA) Newsfilter·2024-05-09 20:00Akoya Biosciences(AKYA) Newsfilter·2024-05-09 20:00
R1Akoya Biosciences(AKYA) Newsfilter·2024-05-09 20:00